MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2025)
MapLight Therapeutics (MPLT) reported Net Equity Issued and Repurchased of $200.0 million for Q4 2025, little changed sequentially from $200.0 million in Q3 2025.
MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $200.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | MapLight Therapeutics | 314.07 Mn | 314.07 Mn | - | 200.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200.00 Mn |
| Dec 31, 2025 | 200.00 Mn |
| Sep 30, 2025 | 200.00 Mn |
| Sep 30, 2025 | 200.00 Mn |